Ting Xu

Peer-Reviewed Articles

1. Hong J, Liao Z, Zhuang Y, Levy LB, Sheu T, Heymach JV, Nguyen QN, Xu T, Komaki R, Gomez DR. Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis. Am J Clin Oncol, 2018. e-Pub 2015. PMID: 26535988.
2. Tang C, Liao Z, Hess K, Chance WW, Zhuang Y, Jensen G, Xu T, Komaki R, Gomez DR. Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer. Acta Oncol 55(8):1022-8, 2016. e-Pub 2016. PMID: 27055359.
3. Li P, Wang X, Liu Z, Liu H, Xu T, Wang H, Gomez DR, Nguyen QN, Wang LE, Teng Y, Song Y, Komaki R, Welsh JW, Wei Q, Liao Z. Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. Clin Lung Cancer 17(4):253-262.e5, 2016. e-Pub 2015. PMID: 26732495.
4. Wang Q, Yu S, Xiao Z, Liu X, Zhang W, Zhang X, He J, Sun K, Xu T, Feng Q, Zhou Z, Wang L, Yin W. Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy. Radiat Oncol 10:142, 2015. e-Pub 2015. PMID: 26159510.
5. Wang H, Liao Z, Zhuang Y, Liu Y, Levy LB, Xu T, Yusuf SW, Gomez DR. Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy. Clin Lung Cancer 16(2):128-36, 2015. e-Pub 2014. PMID: 25450873.
6. Xu T, Liao Z, O'Reilly MS, Levy LB, Welsh JW, Wang LE, Lin SH, Komaki R, Liu Z, Wei Q, Gomez DR. Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer. Radiother Oncol 113(3):379–384, 2014. e-Pub 2014. PMID: 25466375.
7. Wen J, Liu H, Wang Q, Liu Z, Li Y, Xiong H, Xu T, Li P, Wang LE, Gomez DR, Mohan R, Komaki R, Liao Z, Wei Q. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Eur J Cancer 50(10):1706-16, 2014. e-Pub 2014. PMID: 24780874.
8. Tang C, Gomez DR, Wang H, Levy LB, Zhuang Y, Xu T, Nguyen Q, Komaki R, Liao Z. Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(2):319-25, 2014. PMID: 24411603.
9. Wang H, Liao Z, Zhuang Y, Xu T, Nguyen QN, Levy LB, O'Reilly M, Gold KA, Gomez DR. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database. Int J Radiat Oncol Biol Phys 87(5):1071-7, 2013. e-Pub 2013. PMID: 24161424.
10. Yuan X, Wei Q, Komaki R, Liu Z, Yang J, Tucker SL, Xu T, Heymach JV, Lu C, Cox JD, Liao Z. TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy. PLoS One 8(6):e65659, 2013. e-Pub 2013. PMID: 23840350.
11. Pang Q, Wei Q, Xu T, Yuan X, Lopez Guerra JL, Levy LB, Liu Z, Gomez DR, Zhuang Y, Wang LE, Mohan R, Komaki R, Liao Z. Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 85(5):1332-1339, 2013. e-Pub 2013. PMID: 23374503.
12. Xiong H, Liao Z, Liu Z, Xu T, Wang Q, Liu H, Komaki R, Gomez D, Wang LE, Wei Q. ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 85(4):1066-73, 2013. e-Pub 2012. PMID: 23154078.
13. Tucker SL, Li M, Xu T, Gomez D, Yuan X, Yu J, Liu Z, Yin M, Guan X, Wang LE, Wei Q, Mohan R, Vinogradskiy Y, Martel M, Liao Z. Incorporating Single-nucleotide Polymorphisms Into the Lyman Model to Improve Prediction of Radiation Pneumonitis. Int J Radiat Oncol Biol Phys 85(1):251-257, 2013. e-Pub 2012. PMID: 22541966.
14. Xu T, Q. Wei, Lopez Guerra JL, Wang LE, Liu Z, Gomez D, O'Reilly M, Lin SH, Zhuang Y, Levy LB, Mohan R, Zhou H, Liao Z. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(2):e229-35, 2012. e-Pub 2012.
15. Guo Y, Yang TL, Liu YZ, Shen H, Lei SF, Yu N, Chen J, Xu T, Cheng Y, Tian Q, Yu P, Deng HW. Mitochondria-wide association study of common variants in osteoporosis. Ann Hum Genet 75(5):569-74, 2011. e-Pub 2011. PMID: 21762117.
16. Yang TL, Guo Y, Shen H, Lei SF, Liu YJ, Li J, Liu YZ, Yu N, Chen J, Xu T, Cheng Y, Tian Q, Yu P, Papasian CJ, Deng HW. Genetic association study of common mitochondrial variants on body fat mass. PLoS One 6(6):e21595, 2011. e-Pub 2011. PMID: 21747914.

Invited Articles

1. Xu T, Cheng Y, Guo Y, Zhang L, Pei Y, Redger K, Liu Y, Deng H. Design and Interpretation of Linkage and Association Studies on Osteoporosis. Clinic Rev Bone Miner Metab(8):60-67, 2010.

Abstracts

1. Yang J, Xu T, Yuan X, Gomez D.R., Song Y, Komaki R.U., Liao Z. Single Nucleotide Polymorphisms in BMP/Smad4/Hamp Are Associated With Outcome of Patients Receiving Definitive Radiation Therapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 96(2):S156-157. e-Pub 2016.
2. Lan M, Xu T, Yue J, Yang J, Gomez D.R., Jeter M.D., Nguyen Q.N., Shi Q, S.M. Hahn, R.U. Komaki, Wang X, Liao Z. Polymorphisms of BMP4 and HIF-1A Are Associated With Patient-Reported Symptoms in Non-Small-Cell Lung Cancer Patients Treated With Definitive Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 96(2):S199. e-Pub 2016.
3. Lan M, Chen C, Y. Huang, Z. Duan, S. Wu, F. Han, J. Liao, L. Tian, Liao J, Tian L, Zheng L, Xu T, Liao Z, Lu T. The Role of Concurrent Chemotherapy in Patients with Stage IVC Nasopharyngeal Carcinoma Treated With Palliative Chemotherapy Followed by Definitive Radiation Therapy to Primary Tumor. Int J Radiat Oncol Biol Phys 96(2):E360. e-Pub 2016.
4. Xu T, Fan J, Levy L.B., Zhuang Y, Bone C, Huo J, Gomez D.R., Liao Z, and Hu Y. Predictive Value of Serum Hepcidin for Disease Outcome in Non-Small Cell Lung Cancer Patients Received Definitive Radio(chemo)therapy. Int J Radiat Oncol Biol Phys 96(2):E473. e-Pub 2016.
5. Yue J, Jeter M.D., Xu T, Huo J, Pan T, Nguyen Q.N., Komaki R.U., Gomez D.R., Liao Z. Lung Dosimetry, Radiation Pneumonitis, and FDG Uptake in Patients With Stage II-III Non-Small Cell Lung Cancer Treated With Passively Scattered Proton Therapy or Intensity Modulated Photon Therapy. Int J Radiat Oncol Biol Phys 96(2):E455-456. e-Pub 2016.
6. Lin S, Xu T, He J, Banks K, Lanman R, Sebisanovic D, Talasaz A, Lu C, Buchholz T, Hahn S, Komaki R, and Liao Z. Dynamic Changes in Cell-Free Circulating Tumor DNA to Track Tumor Response and Risk of Recurrence in Stage III Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 10(9):S261-406. e-Pub 2015.
7. Lin S, He J, Edelman M, Xu T, Gao H, Reuben J, Qiao Y, Liu H, Amstutz P, Hahn S, Komaki R, Liao Z, Tang C, and Adams D. Sequential Assessment of DNA Damage Response and PD-L1 Expression in Circulating Tumor Cells of Lung Cancer Patients during Radiotherapy. Journal of Thoracic Oncology 10(9):S261-406. e-Pub 2015.
8. Xu T, Qing MH, Gomez DR, Levy LB, Komaki R, Yeh E, Hamilton SR, Mohan R, and Liao Z. Serum Troponin T levels associated with mean radiation dose to heart in non-small-cell lung cancer patients treated with definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 93(3):S411-412. e-Pub 2015.
9. Yang J, Xu T, Gomez DR, Nguyen Q, Yuan X, Song Y, Levy LB, Komaki RU, Liao Z. Single nucleotide polymorphisms in BMP2/BMP4/SMAD4 are associated with severe radiation pneumonitis in patients receiving definitive radiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 93(3):E440-441. e-Pub 2015.
10. Yue J, Xu T, Pan T, Levy LB, Gomez DR, Lu C, Komaki R, Mohan R, and Liao Z. The predictive value of serial 18F-FDG PET/CT for recurrence and survival of locally advanced non-small cell lung cancer after concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 93(3):S430-431. e-Pub 2015.
11. Liu Y, Xu T, Pang Q, Zhuang Y, Lu C, Komaki R, Liao Z, and Gomez DR. EGFR and KRAS mutations and disease outcomes in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 93(3):S435-436. e-Pub 2015.
12. Klass D, Newman A, Zhou L, Stehr H, Xu T, He J, Komaki R, Liao Z, Alizadeh A, Maru D, Lin S, and Diehn M. Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated with Chemoradiotherapy. Int J Radiat Oncol Biol Phys 93(3):S104-105. e-Pub 2015.
13. Wei X, Komaki R, Choi N, O'Reilly M, Fossella F, Chang J, Gomez D, Nguyen Q, Pisters K, Tsao A, Massarelli E, Zhuang Y, Xu T, Hernandez M, Mohan R, and Liao Z. Radiation Dose Escalation to the Gross Tumor Volume Using Simultaneous Integrated Boost Intensity Modulated Photon or Proton Therapy With Concurrent Chemotherapy for Stage II-III Non-Small Cell Lung Cancer: A Preliminary Report of a Phase I Protocol. Int J Radiat Oncol Biol Phys 93(3):S88. e-Pub 2015.
14. Zhou R, Liao Z, Komaki R, Gomez D, Nguyen Q, Zhang Y, Xu T, Liu Y, Yang J, Levy LB. Predictors of In-Field Local Control and Overall Survival in Inoperable Non–Small-Cell Lung Cancer after Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 93(3):S422. e-Pub 2015.
15. Xu T, Gomez DR, O'Reilly M, Nguyen Q, Levy LB, Komaki R, Mohan R, Liao Z. Serum VEGF associated with survival in non-small cell lung cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 90(1):S814. e-Pub 2014.
16. Xu T, Li Y, Deng Z, Hu Y, Liao Z. Nanopore-peptidomics To Predict Response To Chemoradiotherapy For Lung Cancer. Int J Radiat Oncol Biol Phys 90(1):S813. e-Pub 2014.
17. Tang L, Liu A, Gomez DR, Nguyen Q, Xu T, Komaki R, Liao Z. Cardiac Events After Treatment With High Dose Radiation Therapy +/- Chemotherapy For Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 90(1):S161. e-Pub 2014.
18. Liao Z, Mohan R, Xu T, Cox JD, Tucker SL. Comparing Risk Of Radiation Pneumonitis After Intensity-modulated Radiotherapy Vs. Proton Therapy. Int J Radiat Oncol Biol Phys 90(1):S42. e-Pub 2014.
19. Song Y, Xu T, Gomez D, Levy LB, Liao Z. Association of Radiation Pneumonitis Related Single Nucleotide Polymorphisms and Changes in Pulmonary Function in Patients with Non-small Cell Lung Cancer after Definitive Concurrent Chemoradiation. Int J Radiat Oncol Biol Phys 90(1):S813-814. e-Pub 2014.
20. Liu A, Xu T, Gomez D, O'Reilly M, Lin SH, Nguyen Q, Levy LB, Komaki R, Mohan R, Liao Z. Serum CRP Is Predictive Of Survival In Non-small-cell Lung Cancer Patients Treated With Definitive Chemoradiotherapy. Int J Radiat Oncol Biol Phys 90(1):S814. e-Pub 2014.
21. Tang C, Liao Z, Gomez DR, Levy L, Yan Z, Xu T,,Nguyen Q, Komaki R, Welsh J. Lymphopenia association with low lung dose and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys 90(1):S616. e-Pub 2014.
22. Tang C, Gomez DR, Hess K, Zhuang Y, Xu T, Nguyen Q, Komaki R, Liao Z. Predictors of site-specific distant metastasis after definitive radiation therapy in non-small cell lung cancer and the impact of metastatic location on survival. Int J Radiat Oncol Biol Phys 90(1):S616. e-Pub 2014.
23. Xu T, Gomez D, O’Reilly M, Guerrero TM, Nguyen Q, Levy LB, Huo J, Komaki R, Mohan R, Liao Z. Serum TGF-β1 and VEGF are Associated with Tumor Burden and Tumor Response on PET to Radio(chemo)therapy in Patients with Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 87(2):S93. e-Pub 2013.
24. Xu T, Gomez D, O’Reilly M, Levy LB, Welsh J, Lin SH, Komaki R, Liu Z, Wei Q, Liao Z. Circulating miR-155 Predicts for Acute Esophageal Toxicity in Patients with Non-Small-Cell Lung Cancer Treated with Radiation Therapy. Int J Radiat Oncol Biol Phys 87(2):S93-94. e-Pub 2013.